PATENT CLAIM ANALYSIS

Application Number: 15978670
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "04400A"]

Abstract:
The invention relates to a saRNAs useful in upregulating the expression of a target gene and therapeutic compositions comprising the saRNA. Methods of using the saRNA and the therapeutic compositions are also provided.

Claim (Index 2):
The saRNA of  claim 1 , wherein the region between 2000 nucleotides upstream and 2000 nucleotides downstream of the transcription start site has a sequence selected from the group consisting of SEQ ID NO: 2020 (APOA1), 2021 (C19orf80), 2022 (CDKN1B), 2023 (DMD), 2024 (DMD), 2025 (DMD), 2026 (DMD), 2027 (DMD), 2028 (DMD), 2029 (DMD), 2030 (DMD), 2031 (EPO), 2032 (F7), 2033 (F8), 2034 (F8), 2035 (FNDC5), 2036 (FNDC5), 2037 (FOXA2), 2038 (FOXA2), 2039 (FOXP3), 2040 (HNF4A), 2041 (HNF4A), 2042 (IDUA), 2043 (IFNG), 2044 (IL10), 2045 (IL19), 2046 (IL19), 2047 (IL2), 2048 (LDLR), 2049 (LMX1A), 2050 (LMX1A), 2051 (MDM2), 2052 (MDM2), 2053 (METRNL), 2054 (NR4A2), 2055 (PAX5), 2056 (SCN1A), 2057 (SCN1A), 2058 (SIRT1), 2059 (SIRT1), and 2060 (TH).

Metadata:
- Claim Count in Document: 8.0
- Percentile: 93.0
- Lexical Diversity: 1.4
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13877968', '13096817', '15038332', '11910722', '14504303']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7642750377349081
- 35 USC 102 Novelty (BERT): 0.5139149392763273
- Combined Prediction Score: 0.73923902788905
- Mean Citation Score: 239.24641000000005
- Max Citation Score: 247.44456
- Similarity Product: 157.88044301523686

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test